Skip to content

A study to determine the rate of occurrence of pain caused due to nerve damage after surgery in patients with bone and soft tissue cancer.

A prospective observational study to assess the prevalance of neuropathic pain after bone tumor cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032709
Enrollment
278
Registered
2021-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C408- Malignant neoplasm of overlappingsites of bone and articular cartilage of limb

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Hospital
Lead Sponsor
Not Any
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.age group 13-65 years 2.gender: both male and female 3.patients undergoing curative surgery for histologically confirmed bone and soft tissue tumors of the extremities and pelvis with or without adjuvant chemotherapy.

Exclusion criteria

Exclusion criteria: 1. Patients with active symptoms of neuropathic pain or Chemotherapy-induced Peripheral Neuropathy (CIPN) at the time of surgery. 2. Refusal to consent 3. Patients with inability to comprehend or understand the questionnaire

Design outcomes

Primary

MeasureTime frame
To study the incidence of neuropathic pain in patients undergoing BST surgery using NP painDETECT questionnaire 72 hours post-surgery.Timepoint: To study the incidence of neuropathic pain in patients undergoing BST surgery using NP painDETECT questionnaire 72 hours post-surgery.

Secondary

MeasureTime frame
To understand incidence of symptoms similar to but not mounting to neuropathic pain in the post-operative period (painDETECT score 13-18 â??possibleâ?? NP).Timepoint: after 3 month followup;To understand prevalent pain scores and satisfaction to pain management in the study population (to be captured on NRS 0-10).Timepoint: after 3 month followup;To understand the predisposing factors for neuropathic painTimepoint: at the end of study enrollment

Countries

India

Contacts

Public ContactDrSakshi Sharma

Tata Memorial Hospital

pnj5@hotmail.com9869480429

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026